‘$1,600 for $6 meds’: HIV drug prices ‘inflated,’ even though it was developed with taxpayers’ money

An online campaign has been launched against a US drug maker accused of inflating prices of an anti-HIV drug by thousands of dollars. And it turns out the company doesn’t even own the patent for the treatment.